Researchers recently tried an experiment: Gather people who had the same kind of lung cancer and put them on the same type of ...
Live Science on MSN
New triple-drug treatment stops pancreatic cancer in its tracks, a mouse study finds
By targeting three key growth pathways at once, researchers eliminated pancreatic tumors in multiple mouse models and ...
An experimental drug combination was able to effectively treat pancreatic cancer in mouse models without tumor resistance.
A dual-action nanomaterial uses cancer’s own chemistry to destroy tumors while leaving healthy cells unharmed.
Dr. Suneel Kamath, a gastrointestinal medical oncologist at Cleveland Clinic in Ohio and an assistant professor of medicine ...
Moving gemcitabine/nab-paclitaxel to every-other-week dosing decreases infusion visits and may lessen cumulative toxicity, ...
A personalized cancer treatment developed by Moderna Inc. and Merck & Co. helped prevent the recurrence of high-risk skin cancer after five years, new data confirming its prolonged benefit show.
A national clinical trial led by the Alliance for Clinical Trials in Oncology has found that oxybutynin, a drug often used to ...
SurvivorNet on MSN
More control, better quality of life: What to know about tarlatamab, the new immunotherapy drug approved for small-cell lung cancer
Tarlatamab (Imdelltra) is a new type of immunotherapy approved for people with small-cell lung cancer whose disease has ...
Jan 22 (Reuters) - Corcept Therapeutics said on Thursday a late-stage trial showed its experimental drug in combination with chemotherapy helped reduce the risk of death in patients with a type of ...
A cancer treatment has been reformulated into a simple injection after its key components behaved differently in ...
A woman says her family is trying to raise the £2,000-a-month costs in Guernsey for her grandmother's "last option" cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results